Cormedix INC Form 4 insider transactions

Joseph Todisco, CEO of CorMedix Inc., disposed of 26,982 shares of common stock on May 10, 2024, to cover tax obligations.

Director Steven W. Lefkowitz reports the acquisition of stock options in CorMedix Inc.

Director Robert A. Stewart reports the acquisition of 30,000 stock options in CorMedix Inc. on March 5, 2024.

Director Myron Kaplan reports acquisition of 30,000 stock options in CorMedix Inc.

Director Janet Dillione reports acquisition of stock options in CorMedix Inc.

Alan W. Dunton, a director of CorMedix Inc., reported the acquisition of 30,000 stock options on March 5, 2024.

Director Gregory Scott Duncan of CorMedix Inc. reports acquiring 30,000 stock options on March 5, 2024.

CorMedix CEO Joseph Todisco recently purchased 13,561 shares of common stock, increasing his direct holdings in the company.